SEC Form 4 · accession 0001140361-16-078940
ACETO CORP · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Satish Srinivasan
Officer — President & COO - Rising Pharm
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000002034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Sep 1, 2016 | A | 11,000 | $20.03 | A | 26,521 | D | |
| COMMON STOCKF2 | Sep 1, 2016 | A | 10,810 | $20.03 | A | 37,331 | D | |
| COMMON STOCKF3,F4 | Sep 6, 2016 | S | 3,980 | $19.8351 | D | 33,351 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted stock pursuant to long term incentive plan.
- F2Represents vesting of Performance Restricted Stock Units (based upon financial and total shareholder return performance of the Company) from grant of July 25, 2013.
- F3Automatic sale under Rule 10b5-1 to cover the Reporting Person's tax obligation in connection with the vesting of an equity award(s) granted previously.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.7912 to $19.86, inclusive. The reporting person undertakes to provide to Aceto, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above..